Engineering microrobots for targeted cancer therapies from a medical perspective

Разработка микророботов для таргетной терапии рака: медицинский аспект
Oliver G. Schmidt, Richard John Edmondson, Mariana Medina‐Sánchez, Christine K. Schmidt
2020-11-05

bubble-propelled microenginesmicrorobotsmotile bacteriatargeted cancer therapytargeted drug delivery
Systemic chemotherapy remains the backbone of many cancer treatments. Due to its untargeted nature and the severe side effects it can cause, numerous nanomedicine approaches have been developed to overcome these issues. However, targeted delivery of therapeutics remains challenging. Engineering microrobots is increasingly receiving attention in this regard. Their functionalities, particularly their motility, allow microrobots to penetrate tissues and reach cancers more efficiently. Here, we highlight how different microrobots, ranging from tailor-made motile bacteria and tiny bubble-propelled microengines to hybrid spermbots, can be engineered to integrate sophisticated features optimised for precision-targeting of a wide range of cancers. Towards this, we highlight the importance of integrating clinicians, the public and cancer patients early on in the development of these novel technologies.
1
Microrobots are being developed to address the limited targeting and severe side effects associated with systemic chemotherapy.
2
Successful development of cancer-targeting microrobots requires early integration of clinicians, the public, and cancer patients.
3
Tailor-made motile bacteria, bubble-propelled microengines, and hybrid spermbots can incorporate specialized features for precision targeting across diverse cancers.
4
Their motility may enable more efficient tissue penetration and cancer-site access than conventional untargeted therapeutic delivery approaches.

Engineered microrobots for targeted delivery of therapeutics to cancers

Engineering functionalities—particularly motility and precision-targeting features—of diverse microrobots for efficient cancer tissue penetration and targeted cancer therapy

Publication Details
Publication Date
2020-11-05
Journal
Publisher
ISSN
Cited by
465
Access Type
Author Information
Authors
Oliver G. Schmidt
Richard John Edmondson
Mariana Medina‐Sánchez
Christine K. Schmidt
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%